Synopsis
Synopsis
0
KDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Pregna-1,4-diene-3,20-dione, 11,17-dihydroxy-21-(phosphonooxy)-, Disodium Salt, (11.beta.)-
2. Schembl1650407
3. Akos025394281
4. Ft-0631728
| Molecular Weight | 484.4 g/mol |
|---|---|
| Molecular Formula | C21H27Na2O8P |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 3 |
| Exact Mass | 484.12389338 g/mol |
| Monoisotopic Mass | 484.12389338 g/mol |
| Topological Polar Surface Area | 147 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 878 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 7 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
| 1 of 2 | |
|---|---|
| Drug Name | Prednisolone sodium phosphate |
| Active Ingredient | Prednisolone sodium phosphate |
| Dosage Form | Solution/drops; Tablet, orally disintegrating; Solution |
| Route | Ophthalmic; Oral |
| Strength | eq 15mg base/5ml; eq 5mg base/5ml; eq 25mg base/5ml; eq 15mg base; eq 10mg base/5ml; eq 20mg base/5ml; eq 30mg base; eq 0.9% phosphate; eq 10mg base |
| Market Status | Prescription |
| Company | Mylan Pharms; Amneal Pharms; Wockhardt; Pharm Assoc; Mission Pharma; Hi Tech Pharma; Paddock; Vintage; Bausch And Lomb |
| 2 of 2 | |
|---|---|
| Drug Name | Prednisolone sodium phosphate |
| Active Ingredient | Prednisolone sodium phosphate |
| Dosage Form | Solution/drops; Tablet, orally disintegrating; Solution |
| Route | Ophthalmic; Oral |
| Strength | eq 15mg base/5ml; eq 5mg base/5ml; eq 25mg base/5ml; eq 15mg base; eq 10mg base/5ml; eq 20mg base/5ml; eq 30mg base; eq 0.9% phosphate; eq 10mg base |
| Market Status | Prescription |
| Company | Mylan Pharms; Amneal Pharms; Wockhardt; Pharm Assoc; Mission Pharma; Hi Tech Pharma; Paddock; Vintage; Bausch And Lomb |
GDUFA
DMF Review : Complete
Rev. Date : 2016-06-10
Pay. Date : 2016-05-27
DMF Number : 23899
Submission : 2010-06-18
Status : Active
Type : II
Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
GDUFA
DMF Review : Complete
Rev. Date : 2014-02-12
Pay. Date : 2013-09-12
DMF Number : 22624
Submission : 2009-03-13
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2376
Submission : 1974-12-18
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5583
Submission : 1984-11-05
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3819
Submission : 1980-05-21
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 758
Submission : 1963-12-16
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21822
Submission : 2008-07-24
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9307
Submission : 1991-08-22
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4604
Submission : 1982-07-18
Status : Inactive
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prednisolone Sodium Phosphate, Process 2
Certificate Number : R1-CEP 2016-205 - Rev 01
Status : Valid
Issue Date : 2023-06-12
Type : Chemical
Substance Number : 735
Certificate Number : R1-CEP 2011-149 - Rev 01
Status : Valid
Issue Date : 2022-02-15
Type : Chemical
Substance Number : 735
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : CEP 2023-025 - Rev 00
Status : Valid
Issue Date : 2025-03-04
Type : Chemical
Substance Number : 735

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Prednisolone Sodium Phosphate, Process C
Certificate Number : CEP 2023-402 - Rev 00
Status : Valid
Issue Date : 2024-04-11
Type : Chemical
Substance Number : 735

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : R1-CEP 2016-329 - Rev 00
Status : Valid
Issue Date : 2023-07-13
Type : Chemical
Substance Number : 735

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] About the Company : Symbiotec, based in Indore, India, is a leading API manufacturer specializing in cortico-steroids and steroid-hormone APIs since 1995. Focused on R&D, sustainability, and innovatio...
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
About the Company : Gonane Pharma is a contract pharmaceutical company based in Gujarat, India, specializing in the manufacturing and marketing of corticosteroids, hormones, antivirals, and oncology p...
Symbiotica delivers high-quality APIs through advanced R&D, GMP-certified manufacturing, & trusted global pharmaceutical partnerships.
About the Company : Symbiotica is a Malaysia-based manufacturer of high-quality Active Pharmaceutical Ingredients (APIs), specialising in steroidal, hormonal, and niche non-steroidal compounds for glo...
About the Company : Jai Radhe Sales, founded in 1999, is a global distributor specializing in high-quality pharmaceutical ingredients from India. It offers complete sourcing solutions, technical and r...
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...
Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
About the Company : Curia is a global contract research, development and manufacturing organization (CDMO), offering products and services across the drug development spectrum to help our partners tur...
About the Company : We take pride and pleasure to introduce “Envee Drugs Pvt. Ltd.” a leading manufacturer of Active Pharmaceutical Ingredients (APIs). Envee Drugs is a API manufacturer since 1998...

About the Company : Great Pacific Exports is a trusted manufacturer and exporter of Active Pharmaceutical Ingredients (APIs) and specialty chemicals, with a legacy spanning over five decades in textil...

About the Company : Mahima Life Sciences Pvt. Ltd. stands as a prominent manufacturer and exporter of Corticosteroids, APIs, and Vitamins, based in New Delhi, India, boasting a robust global presence ...

About the Company : Rumit group of companies is a young, dynamic & Robustly growing company established in 1993. We specialise in pharmaceutical raw material, Bulk API, dye stuff, dyes intermediates &...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
59
PharmaCompass offers a list of Prednisolone Sodium Phosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Prednisolone Sodium Phosphate manufacturer or Prednisolone Sodium Phosphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Prednisolone Sodium Phosphate manufacturer or Prednisolone Sodium Phosphate supplier.
PharmaCompass also assists you with knowing the Prednisolone Sodium Phosphate API Price utilized in the formulation of products. Prednisolone Sodium Phosphate API Price is not always fixed or binding as the Prednisolone Sodium Phosphate Price is obtained through a variety of data sources. The Prednisolone Sodium Phosphate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Vasocidin Solution manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vasocidin Solution, including repackagers and relabelers. The FDA regulates Vasocidin Solution manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vasocidin Solution API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vasocidin Solution manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Vasocidin Solution supplier is an individual or a company that provides Vasocidin Solution active pharmaceutical ingredient (API) or Vasocidin Solution finished formulations upon request. The Vasocidin Solution suppliers may include Vasocidin Solution API manufacturers, exporters, distributors and traders.
click here to find a list of Vasocidin Solution suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Vasocidin Solution DMF (Drug Master File) is a document detailing the whole manufacturing process of Vasocidin Solution active pharmaceutical ingredient (API) in detail. Different forms of Vasocidin Solution DMFs exist exist since differing nations have different regulations, such as Vasocidin Solution USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Vasocidin Solution DMF submitted to regulatory agencies in the US is known as a USDMF. Vasocidin Solution USDMF includes data on Vasocidin Solution's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Vasocidin Solution USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Vasocidin Solution suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Vasocidin Solution Drug Master File in Japan (Vasocidin Solution JDMF) empowers Vasocidin Solution API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Vasocidin Solution JDMF during the approval evaluation for pharmaceutical products. At the time of Vasocidin Solution JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Vasocidin Solution suppliers with JDMF on PharmaCompass.
A Vasocidin Solution CEP of the European Pharmacopoeia monograph is often referred to as a Vasocidin Solution Certificate of Suitability (COS). The purpose of a Vasocidin Solution CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Vasocidin Solution EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Vasocidin Solution to their clients by showing that a Vasocidin Solution CEP has been issued for it. The manufacturer submits a Vasocidin Solution CEP (COS) as part of the market authorization procedure, and it takes on the role of a Vasocidin Solution CEP holder for the record. Additionally, the data presented in the Vasocidin Solution CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Vasocidin Solution DMF.
A Vasocidin Solution CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Vasocidin Solution CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Vasocidin Solution suppliers with CEP (COS) on PharmaCompass.
A Vasocidin Solution written confirmation (Vasocidin Solution WC) is an official document issued by a regulatory agency to a Vasocidin Solution manufacturer, verifying that the manufacturing facility of a Vasocidin Solution active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Vasocidin Solution APIs or Vasocidin Solution finished pharmaceutical products to another nation, regulatory agencies frequently require a Vasocidin Solution WC (written confirmation) as part of the regulatory process.
click here to find a list of Vasocidin Solution suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Vasocidin Solution as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Vasocidin Solution API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Vasocidin Solution as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Vasocidin Solution and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Vasocidin Solution NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Vasocidin Solution suppliers with NDC on PharmaCompass.
Vasocidin Solution Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vasocidin Solution GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vasocidin Solution GMP manufacturer or Vasocidin Solution GMP API supplier for your needs.
A Vasocidin Solution CoA (Certificate of Analysis) is a formal document that attests to Vasocidin Solution's compliance with Vasocidin Solution specifications and serves as a tool for batch-level quality control.
Vasocidin Solution CoA mostly includes findings from lab analyses of a specific batch. For each Vasocidin Solution CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vasocidin Solution may be tested according to a variety of international standards, such as European Pharmacopoeia (Vasocidin Solution EP), Vasocidin Solution JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vasocidin Solution USP).